Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 11, 2004, Pages 1871-1872

  Pengo, Vittorio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERY OCCLUSION; ATHEROSCLEROTIC PLAQUE; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL OBSERVATION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; HYPOTHESIS; LONG TERM CARE; NOTE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PERFUSION; PRIORITY JOURNAL; RECANALIZATION; RISK ASSESSMENT; RISK REDUCTION; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VENOUS STASIS;

ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DEMENTIA; HUMANS; TIME; WARFARIN;

EID: 13244260722     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01013.x     Document Type: Note

References (19)

1. Wolf PA, Dawber TR, Thomas E Jr, Kannel WB. Epidemiological assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978; 28: 973-7.
2. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986; 43: 71-84.
3. Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL. Pathophysiologic correlates of thromboembolism in non-va1vular atrial fibrillation: reduced flow velocity in the left atrial appendage. J Am Soc Echocardiogr 1999; 12: 1080-7.
4. Hart RG, Halperin JL. Atrial fibrillation and stroke. Concepts and controversies. Stroke 2001; 32: 803-8.
5. Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997; 77: 407-11.
6. Vene M, Mavri A, Kosmelj K, Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003; 90: 1163-72.
7. Fukuchi M, Watanabe J, Kumagai K, Katori Y, Baba S, Fukuda K, Yagi T, Iguchi A, Yokoyama H, Miura M, Kagaya Y, Sato S, Tabayashi K, Shirato K. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001; 37: 1436-42.
8. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PE, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42: 289-98.
9. Yatsu FM, Shaltoni HM. Implications of silent strokes. Curr Atherosler Rep 2004; 6: 307-13.
10. Vermeer SE, Prins ND, den Heijer T, Holman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-22.
11. Kilander L, Andren B, Nyman H, Lind L, Boberg M, Lithell H. Atrial fibrillation is an independent determinant of low cognitive function. Stroke 1998; 29: 1816-20.
12. Bernick C, Kuller L, Dulberg C. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology 2001; 57: 1222-9.
13. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Hayes-Kelly M, Wolf PA. Dementia after stroke. The Framingham Study. Stroke 2004; 35: 1264-9.
14. Fisher CM. Capsular infarets: the underlying vascular lesions. Arch Neurol 1979; 36: 65-73.
15. Ay H, Oliveira-Filho J, Buonanno FS, Ezzeddine M, Shaefer PW, Rordorf G, Schwamm LH, Gonzales RG, Koroshetz WJ. Diffusion-weighted imaging identifies a subset of lacunar infarction associated with embolic source. Stroke 1999; 30: 2644-50.
16. Barber M, Campbell Tait R, Scott J, Rumley A, Lowe GDO, Stott DJ. Dementia in subjects with atrial fibrillation: haemostatic function and the role of anticoagulation. J Thromb Haemost 2004; 2: 1873-8.
17. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 1969; 12: 1-15.
18. Viles-Gonzales JF, Anand SX, Valdiviezo C, Uroojzafar M, Sanz J, Rius T, Poon M, Fuster V, Badimon JJ. Update in atherothrombotic disease. Mount Sinai J Med 2004; 71: 197-208.
19. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, Bovill EG. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 1999; 30: 2547-53.